<?xml version="1.0" encoding="UTF-8"?>
<list>
  <sentences>
    <s path="[OANC]/data/written_2/technical/biomed/1475-2875-2-14.anc" start="19642" end="19647" sStart="19549" offset="93" sid="r7.1.use.v.0990" wn="1" wnkey="use%2:34:01::" annotator="jeneale" text="For the toxicity experiments, the significance of multiple treatments was assessed using one-way ANOVA and Dunnett's t-test." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1475-2875-2-14.anc" start="6967" end="6978" sStart="null" offset="0" sid="null" wn="2" wnkey="transfer%2:40:01::" annotator="veweser" text="For imaging experiments the neurons were &lt;b&gt;transferred&lt;/b&gt; to 4-chamber cover glass slides that had been previously coated with poly-L-lysine followed by collagen." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1475-2875-2-14.anc" start="6967" end="6978" sStart="null" offset="0" sid="null" wn="2 3" wnkey="null" annotator="tofox" text="For imaging experiments the neurons were &lt;b&gt;transferred&lt;/b&gt; to 4-chamber cover glass slides that had been previously coated with poly-L-lysine followed by collagen." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1475-2875-2-14.anc" start="6967" end="6978" sStart="null" offset="0" sid="null" wn="2" wnkey="transfer%2:40:01::" annotator="jeneale" text="For imaging experiments the neurons were &lt;b&gt;transferred&lt;/b&gt; to 4-chamber cover glass slides that had been previously coated with poly-L-lysine followed by collagen." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1475-2875-2-14.anc" start="6967" end="6978" sStart="null" offset="0" sid="null" wn="2 4" wnkey="null" annotator="carichter" text="For imaging experiments the neurons were &lt;b&gt;transferred&lt;/b&gt; to 4-chamber cover glass slides that had been previously coated with poly-L-lysine followed by collagen." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1475-2875-2-14.anc" start="6967" end="6978" sStart="null" offset="0" sid="null" wn="2 4" wnkey="null" annotator="carichter" text="For imaging experiments the neurons were &lt;b&gt;transferred&lt;/b&gt; to 4-chamber cover glass slides that had been previously coated with poly-L-lysine followed by collagen." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1475-2875-2-14.anc" start="7231" end="7242" sStart="null" offset="0" sid="null" wn="2" wnkey="transfer%2:40:01::" annotator="carichter" text="For the array studies, the neurons (20 ? 10 6neurons per flask) were &lt;b&gt;transferred&lt;/b&gt; to 75 cm 2flasks." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1475-2875-2-14.anc" start="38201" end="38205" sStart="null" offset="0" sid="null" wn="1" wnkey="time%1:11:00::" annotator="elstickles" text="Mefloquine accumulates to plasma concentrations of 3.8 and 2.1-23 ?M after administration at prophylactic dose and therapeutic dosing respectively [ 3 4 ] . Therefore, only at the &lt;b&gt;time&lt;/b&gt; of peak plasma concentrations in a few patients, do mefloquine plasma concentrations approach the threshold necessary (&gt; 10 ?M) to induce any of the effects observed in the present study." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1475-2875-2-14.anc" start="38201" end="38205" sStart="null" offset="0" sid="null" wn="3" wnkey="time%1:28:00::" annotator="carichter" text="Mefloquine accumulates to plasma concentrations of 3.8 and 2.1-23 ?M after administration at prophylactic dose and therapeutic dosing respectively [ 3 4 ] . Therefore, only at the &lt;b&gt;time&lt;/b&gt; of peak plasma concentrations in a few patients, do mefloquine plasma concentrations approach the threshold necessary (&gt; 10 ?M) to induce any of the effects observed in the present study." />
    <s path="[OANC]/data/written_2/technical/biomed/1475-2875-2-14.anc" start="16197" end="16207" sStart="null" offset="16" sid="r10.particular.j.0297" wn="2" wnkey="particular%5:00:02:specific:00" annotator="veweser" text="For a particular treatment group, a gene was considered to have differentially modulated expression where the fold-change in expression exceeded 1.3." />
    <s path="[OANC]/data/written_2/technical/biomed/1475-2875-2-14.anc" start="36178" end="36183" sStart="null" offset="97" sid="r9.level.n.0967" wn="2" wnkey="level%1:26:01::" annotator="cgozo" text="Firstly, the trigger for the sustained elevation in cytoplasmic calcium may occur at the level of the ER, and secondly, this effect may also contribute substantially to the neurotoxicity of mefloquine." />
    <s path="[OANC]/data/written_2/technical/biomed/1475-2875-2-14.anc" start="16486" end="16491" sStart="null" offset="125" sid="r9.level.n.0931" wn="1" wnkey="level%1:07:00::" annotator="cgozo" text="Fold-changes (FC) in expression were defined as: = mean mefloquine expression level/mean DMSO expression level." />
    <s path="[OANC]/data/written_2/technical/biomed/1475-2875-2-14.anc" start="8772" end="8778" sStart="null" offset="38" sid="r9.level.n.0840" wn="2" wnkey="level%1:26:01::" annotator="brubin" text="To compare the fluorescence levels in different neurons (which were often in slightly different focal planes) on different days, the fluorescence readings at each time point were normalized to the first one taken for each neuron." />
    <s path="[OANC]/data/written_2/technical/biomed/1475-2875-2-14.anc" start="28218" end="28224" sStart="null" offset="184" sid="r9.level.n.0946" wn="1" wnkey="level%1:07:00::" annotator="anfahmy" text="Relative transcriptional changes at each concentration for GRP78, GADD153 and PERK are shown in Figure 6. Mefloquine induced no significant change in the levels of ?-tubulin mRNA (Table 2, Figure 6)." />
    <s path="[OANC]/data/written_2/technical/biomed/1475-2875-2-14.anc" start="21451" end="21457" sStart="null" offset="195" sid="r9.level.n.0902" wn="1" wnkey="level%1:07:00::" annotator="anfahmy" text="Glutamate induces the activation of plasma membrane influx channels, therefore its failure to illicit a calcium response shows that the external media contained low levels of free calcium." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1475-2875-2-14.anc" start="36705" end="36710" sStart="null" offset="0" sid="null" wn="4" wnkey="know%2:31:00::" annotator="carichter" text="Our laboratory is currently investigating the possibility that &lt;b&gt;known&lt;/b&gt; inhibitors of store-mediated calcium entry (e.g." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1475-2875-2-14.anc" start="6138" end="6144" sStart="null" offset="0" sid="null" wn="1" wnkey="island%1:17:00::" annotator="veweser" text="Biosource International, Rockville, MD, and GIBCO/Life Technologies, Grand &lt;b&gt;Island&lt;/b&gt;, NY." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1475-2875-2-14.anc" start="6138" end="6144" sStart="null" offset="0" sid="null" wn="2147483647" wnkey="null" annotator="tofox" text="Biosource International, Rockville, MD, and GIBCO/Life Technologies, Grand &lt;b&gt;Island&lt;/b&gt;, NY." />
    <s path="[OANC]/data/written_2/technical/biomed/1475-2875-2-14.anc" start="39045" end="39053" sStart="null" offset="214" sid="r11.function.n.0622" wn="3" wnkey="function%1:04:00::" annotator="vebatchelder" text="Thus, mefloquine apparently crosses the blood-brain barrier and accumulates to sufficient levels to include those concentrations found to disrupt neuronal calcium homeostasis and ER function in vitro . The possibility that a disruption of neuronal calcium homeostasis or ER function may be responsible, at least in part, for the clinical neurotoxicity of mefloquine is worthy of further investigation." />
    <s path="[OANC]/data/written_2/technical/biomed/1475-2875-2-14.anc" start="39154" end="39162" sStart="null" offset="323" sid="r11.function.n.0501" wn="2" wnkey="function%1:07:00::" annotator="adelpriore" text="Thus, mefloquine apparently crosses the blood-brain barrier and accumulates to sufficient levels to include those concentrations found to disrupt neuronal calcium homeostasis and ER function in vitro . The possibility that a disruption of neuronal calcium homeostasis or ER function may be responsible, at least in part, for the clinical neurotoxicity of mefloquine is worthy of further investigation." />
    <s path="[OANC]/data/written_2/technical/biomed/1475-2875-2-14.anc" start="38750" end="38754" sStart="null" offset="2" sid="r9.fold.v.0465" wn="2147483645" wnkey="null" annotator="veweser" text="5-fold with absolute, equivalent concentrations exceeding 90 ?M (Table 3)." />
    <s path="[OANC]/data/written_2/technical/biomed/1475-2875-2-14.anc" start="3259" end="3266" sStart="null" offset="49" sid="r9.fold.v.0182" wn="" wnkey="null" annotator="anfahmy" text="ER function is critical if protein synthesis and folding is to successfully occur in eukaryotic cells [ 11 12 ] . ER stress, induced by cellular events as diverse as disrupted calcium homeostasis, elevated levels of reactive oxygen species and viral infection, leads to accumulation of dysfunctional ER chaperones and misfolded proteins [ 11 ] . Cells respond by one or both of two conserved stress response pathways." />
    <s path="[OANC]/data/written_2/technical/biomed/1475-2875-2-14.anc" start="13436" end="13443" sStart="null" offset="87" sid="r10.control.n.0105" wn="4" wnkey="control%1:09:02::" annotator="veweser" text="After 5 min, the media were replaced with MEM containing 0.02% DMSO (for the control, 10 and 80 ?M mefloquine treatment groups) or 2 ?M mefloquine for a further 24 h." />
    <s path="[OANC]/data/written_2/technical/biomed/1475-2875-2-14.anc" start="14480" end="14488" sStart="null" offset="482" sid="r10.control.n.0211" wn="4" wnkey="control%1:09:02::" annotator="cgozo" text="Detailed procedures for preparation of cDNA and fluorescently labeled cRNA, hybridization, staining, and scanning of gene chips and assay monitoring are outlined in earlier literature [ 15 ] . The platform chosen for global expression profile was the Rat Genome U34 Array (Affymetrix, Santa Clara, California), which contains probes for a total of 8799 expressed sequence tag (EST) clusters and genes (including controls)." />
    <s path="[OANC]/data/written_2/technical/biomed/1475-2875-2-14.anc" start="18145" end="18153" sStart="null" offset="73" sid="r10.control.n.0944" wn="4" wnkey="control%1:09:02::" annotator="brubin" text="Effects of the various treatments were compared to appropriate controls (Locke's solution with and without calcium and/or 1 mM EGTA for 15 minutes)." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1475-2875-2-14.anc" start="12803" end="12808" sStart="null" offset="0" sid="null" wn="1" wnkey="add%2:30:00::" annotator="cgozo" text="4%) were &lt;b&gt;added&lt;/b&gt; after scan 13 and DMSO (0." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1475-2875-2-14.anc" start="23033" end="23038" sStart="null" offset="0" sid="null" wn="1" wnkey="add%2:30:00::" annotator="cgozo" text="As can be seen from Figure 2, exposure to this buffer for 10 minutes was required to reduce the viability of the neurons below that induced by treatment of neurons with Locke's containing no &lt;b&gt;added&lt;/b&gt; calcium (one way ANOVA and Dunnett's test, P &lt; 0.05, n = 44)." />
  </sentences>
</list>